Pregnancy after liver transplantation: Can renal function quell the fear?
Nancy Reau – 6 April 2018
Should organs from hepatitis C‐positive donors be used in hepatitis C‐negative recipients for liver transplantation?
Nazia Selzner, Marina Berenguer – 6 April 2018 – Given the scarcity of donated organs and the frequency of death on the waiting list, strategies that could improve the available supply of high‐quality liver grafts are much needed. Direct‐acting antiviral agent (DAA) regimens have proved to be highly effective to treat hepatitis C virus (HCV), even in the setting of posttransplantation. The question arises as to whether transplant communities should consider the utilization of HCV‐positive donors into HCV‐negative recipients.
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach – 6 April 2018
Hepatitis C: Who should treat hepatitis C virus? The role of the primary care provider
Tram T. Tran – 6 April 2018
Reply
Samarth S. Patel, Mohammad Shadab Siddiqui – 6 April 2018
Early liver transplantation for severe alcoholic hepatitis
Jonathan Nahas, Gene Y. Im – 6 April 2018
Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Patrick R. Varley, Julie Goswami, Hamza O. Yazdani, Samer Tohme, Patricia Loughran, Robert M. O'Doherty, Marta I. Minervini, Hai Huang, Richard L. Simmons, Allan Tsung – 6 April 2018 – Nonalcoholic steatohepatitis (NASH) is a progressive, inflammatory form of fatty liver disease. It is the most rapidly rising risk factor for the development of hepatocellular carcinoma (HCC), which can arise in NASH with or without cirrhosis. The inflammatory signals promoting the progression of NASH to HCC remain largely unknown.
Multiple admissions for acetaminophen overdose: Acetaminophen frequent fliers, a new entity?
Edward Yang, Lan Peng, William M. Lee – 6 April 2018
Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection
Jacob George, Eduard Burnevich, I‐Shyan Sheen, Jeong Heo, Nguyen Van Kinh, Tawesak Tanwandee, Pin‐Nan Cheng, Do Young Kim, Won Young Tak, Svetlana Kizhlo, Konstantin Zhdanov, Vasily Isakov, Liwen Liang, Pauline Lindore, Joy Ginanni, Bach‐Yen Nguyen, Janice Wahl, Eliav Barr, Michael Robertson, Paul Ingravallo, Rohit Talwani, on behalf of the C‐CORAL Study Investigators – 4 April 2018 – The prevalence of hepatitis C virus (HCV) infection in Asian countries is high.
Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection
Jacob George, Eduard Burnevich, I‐Shyan Sheen, Jeong Heo, Nguyen Van Kinh, Tawesak Tanwandee, Pin‐Nan Cheng, Do Young Kim, Won Young Tak, Svetlana Kizhlo, Konstantin Zhdanov, Vasily Isakov, Liwen Liang, Pauline Lindore, Joy Ginanni, Bach‐Yen Nguyen, Janice Wahl, Eliav Barr, Michael Robertson, Paul Ingravallo, Rohit Talwani, on behalf of the C‐CORAL Study Investigators – 4 April 2018 – The prevalence of hepatitis C virus (HCV) infection in Asian countries is high.